Tronox Pigmentos do Brasil SA

Tronox Pigmentos do Brasil SA has a current liquidity position of 4.9, indicating strong short-term financial health, but its negative operating cash flow of -79,355,000 BRL suggests ongoing cash outflows from operations. The company's debt-to-equity ratio is 0.01, showing minimal leverage, but its negative free cash flow of -1,835,000 BRL indicates limited capacity to fund growth or dividends.

The company's return on equity is -0.35%, and return on assets is -0.25%, both significantly below the industry median for Specialty Chemicals, which typically exceeds 10% ROE and 5% ROA. This underperformance suggests operational inefficiencies or pricing pressures.

Tronox Pigmentos do Brasil SA's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes.

The company's revenue has declined in the current fiscal year, with no clear signs of recovery in the next fiscal year. The negative operating income of -7,093,000 BRL and net loss of -2,363,000 BRL highlight ongoing profitability challenges.

The company faces medium liquidity risk due to its negative operating cash flow and low dilution risk, as there is no indication of imminent share issuance. The negative free cash flow and operating cash flow suggest the company may need to seek external financing, which could affect its capital structure.

Recent filings indicate a net loss for the period, with no significant events disclosed in transcripts or other public communications that would suggest a turnaround in operations or strategy.

Revenue grew 20% year-over-year to BRL 793 million, demonstrating significant top-line expansion despite recent operational challenges.

The company maintains a minimal debt-to-equity ratio of 0.01, ranking in the top quartile for financial leverage safety.

Cash conversion metrics are best-in-class at 33.58, significantly outperforming the cohort median of 1.08.

Net income improved by 41.4% year-over-year, indicating a strong trajectory toward profitability recovery.

Dilution risk is assessed as low, suggesting current capital structure stability for existing shareholders.

Operating margin stands at -5.1%, placing the company in the bottom quartile compared to the 6.0% cohort median.

The company reported a net loss of BRL 66.6 million in the latest fiscal year, resulting in negative returns.

Return on equity is negative at -0.35%, significantly underperforming the positive 3.93% median for the specialty chemicals cohort.

Credit risk is flagged as high, indicating potential difficulties in meeting financial obligations or securing favorable financing.

Free cash flow remains negative at BRL -78 million, highlighting ongoing cash burn despite revenue growth.